H Pylori
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2007; 13(21): 2923-2931
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2923
Table 3 Plasma cytokine contents in patients with CagA+ H pylori infection (mean ± SE, pg/mL)
Pathological diagnosisIFN-γIL-4IL-12IL-10IL-6IL-2
Normal mucosa (NM, n = 37)27.46 ± 1.0510.86 ± 0.6281.42 ± 1.8966.92 ± 2.1547.96 ± 1.9954.17 ± 1.09
Chronic gastritis (CG, n = 170)28.94 ± 0.5911.22 ± 0.4572.49 ± 0.9380.65 ± 0.9963.40 ± 1.5745.95 ± 0.49
Gastric atrophy (GA, n = 88)30.48 ± 0.7511.23 ± 0.3353.29 ± 0.79100.80 ± 1.6994.10 ± 2.5739.61 ± 0.69
Intestinal metaplasia (IM, n = 80)31.71 ± 1.0212.08 ± 0.5952.18 ± 0.94104.18 ± 1.90112.03 ± 2.6434.07 ± 0.54
Dysplasia (DP, n = 57)30.14 ± 1.0410.92 ± 0.3943.30 ± 1.10157.72 ± 2.64156.74 ± 3.6632.71 ± 0.81
Gastric cancer (GC, n = 74)31.00 ± 0.8411.03 ± 0.2939.10 ± 0.89196.65 ± 1.83159.32 ± 2.5728.39 ± 0.65